VJNeurology is committed to improving our service to you

Share this video  

VJNeurology is committed to improving our service to you

CONy 2020 | The unmet needs of migraine patients

Jessica Ailani, MD, MedStar Georgetown University Hospital, Georgetown, Washington, DC, discusses the unmet needs in the migraine field. There are very limited non-oral medication options. For patients with nausea and vomiting, other options are needed as rescue therapy. Additionally, some patients do not respond to current medications. Therefore, there also needs to be more medication targeting different biological pathways other than CGRP. This interview took place during the Virtual World Congress on Controversies in Neurology (CONy) 2020.


Dr. Ailani has received honoraria for consulting from the following companies; Amgen, Abbvie, Biohaven, Eli Lilly and Company, Lundbeck, Teva, Impel, Satsuma, Theranica, Axsome, Vorso. She has received stock options from CtrlM for consulting. She has received honoraria for speaking engagements from the following companies; Abbvie, Amgen, Biohaven, Eli Lilly, Lundbeck, and Teva. Dr. Ailani’s institution has received funding for clinical trials for her work as principal investigator from the following companies; Allergan/Abbvie, Biohaven, Eli Lilly and Company, Satsuma, Zosano. She has provided advising and editorial services and received honoraria from the following journals/magazines/and companies; Current pain and headache reports, SELF, Neurology Live, and Medscape.